⌘K
Loading ticker…
Immunome, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Immunome, Inc. (IMNM) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.9%, relative volume 2.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
36 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
IMNM is in a stage 3 topping pattern, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.1% / 1.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
IMNM is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $69M notional. Top 3 carry $188M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $69M |
| XBIState Street SPDR S&P Biotech ETF | 0.86% | $64M |
| IWMiShares Russell 2000 ETF | 0.08% | $54M |
| VXFVanguard Extended Market ETF | 0.03% | $25M |
| IWOiShares Russell 2000 Growth ETF | 0.15% | $18M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMNM Jan avg: 53.18% median: 34.74% win: 100% σ: 61.51% n: 4 2022-04-12 → 2026-05-29 | IMNM Feb avg: 1.61% median: -12.41% win: 25% σ: 29.66% n: 4 2022-04-12 → 2026-05-29 | IMNM Mar avg: -4.30% median: 1.01% win: 75% σ: 16.55% n: 4 2022-04-12 → 2026-05-29 | IMNM Apr avg: -6.74% median: -4.01% win: 40% σ: 27.80% n: 5 2022-04-12 → 2026-05-29 | IMNM May avg: 2.79% median: 3.46% win: 60% σ: 5.57% n: 5 2022-04-12 → 2026-05-29 | IMNM Jun avg: 5.16% median: -5.66% win: 50% σ: 32.63% n: 4 2022-04-12 → 2026-05-29 (current) | IMNM Jul avg: 13.00% median: 17.07% win: 75% σ: 16.08% n: 4 2022-04-12 → 2026-05-29 | IMNM Aug avg: 6.69% median: -5.55% win: 25% σ: 27.65% n: 4 2022-04-12 → 2026-05-29 | IMNM Sep avg: 6.56% median: 9.72% win: 50% σ: 24.20% n: 4 2022-04-12 → 2026-05-29 | IMNM Oct avg: 4.82% median: 1.79% win: 50% σ: 24.43% n: 4 2022-04-12 → 2026-05-29 | IMNM Nov avg: 4.18% median: 6.91% win: 50% σ: 15.33% n: 4 2022-04-12 → 2026-05-29 | IMNM Dec avg: -2.62% median: -2.51% win: 50% σ: 40.80% n: 4 2022-04-12 → 2026-05-29 |